Skip to content
FDA drug shortage status

Is Somatropin Injection (Norditropin) in shortage?

Somatropin Injection is listed by FDA as being discontinued by at least one maker (updated Nov 13, 2026).

Being discontinuedFDA status
1packages listed
0unavailable

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Zomacton, Injection, 5 mg; 4.8 mg; 10 mg (NDC 55566-1801-1)
    Ferring Pharmaceuticals Inc.Being discontinuedUpdated Nov 13, 2026Discontinued Nov 13, 2026

    Discontinuation of the manufacture of the drug

    Maker contact: 888-337-7464

No longer on FDA’s list (1)

These packages were on FDA’s shortage list and have since been removed (last seen Nov 16, 2026). Removal usually means supply recovered.

  • Norditropin, Injection, 30 mg/3 mL (NDC 0169-7703-21)

FDA recalls of Somatropin

Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Somatropin Injection:

Somatropin Injection shortage questions

Is Somatropin Injection (Norditropin) in shortage?

Somatropin Injection is listed by FDA as being discontinued by at least one maker (updated Nov 13, 2026).

What should I do if I can’t get Somatropin Injection?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.